Endurant Capital Management’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-58,240
| Closed | -$558K | – | 71 |
|
|
2018
Q4 | $558K | Sell |
58,240
-12,528
| -18% | -$120K | 0.29% | 44 |
|
|
2018
Q3 | $856K | Buy |
70,768
+16,264
| +30% | +$197K | 0.38% | 50 |
|
|
2018
Q2 | $851K | Sell |
54,504
-72,496
| -57% | -$1.13M | 0.37% | 49 |
|
|
2018
Q1 | $1.91M | Sell |
127,000
-79,400
| -38% | -$1.19M | 0.71% | 37 |
|
|
2017
Q4 | $2.97M | Buy |
+206,400
| New | +$2.97M | 0.91% | 40 |
|
|
2017
Q3 | – | Sell |
-118,800
| Closed | -$1.2M | – | 91 |
|
|
2017
Q2 | $1.2M | Sell |
118,800
-104,500
| -47% | -$1.05M | 0.34% | 62 |
|
|
2017
Q1 | $1.59M | Sell |
223,300
-2,000
| -0.9% | -$14.3K | 0.51% | 53 |
|
|
2016
Q4 | $1.12M | Buy |
225,300
+182,400
| +425% | +$907K | 0.46% | 48 |
|
|
2016
Q3 | $317K | Buy |
+42,900
| New | +$317K | 0.12% | 88 |
|